Made with ❤️ by True Sparrow

Bringing you the latest funding data

Baseimmune

Last funding round

Raised
$11,400,000
Round
Unknown

Funding News (1)

Feb 20 2024Sifted

Startup details

Baseimmune

Baseimmune

Baseimmune is a UK-based biotech startup focused on developing 'mutation-proof' vaccines using a prediction algorithm that analyzes genomic, epidemiological, immunological, clinical, and evolutionary data to create artificial antigens drawn from the entire pathogen’s genome.
www.baseimmune.co.uk
London, United Kingdom
Established in 2019
11-50 People
Healthcare, Drug Discovery and Delivery

Founders

Joshua Blight

Joshua Blight

Co-Founder & CEO

Ex: Imperial College London, P4 price, Freelance, KQ Labs, University of Delaware, PERRIGO PHARMA LIMITED, NHS

United Kingdom

Investment details

Total Funding
$17,400,000
Raised
$11,400,000
Round
Unknown
Investors
IQ Capital
LEAD

Founder Stories

Dr. Sterghois Moschos, PulmoBioMed

Recent 5 from United Kingdom

May2024
1

Today

Bicycle raised $555M from Forbion and 6 others
UK-based Bicycle Therapeutics develops precision-guided therapeutics using 'bicycle' molecules for cancer and disease treatment.
Bicycle

Founders

Sir Gregory Winter

In News

Tech.eu
2

1 day ago

Viable raised a $3M Seed led by Martin Brailsford
London-based Viable is an Intelligent Finance platform for online and multi-channel sellers.
Viable

Founders

Henry Young,

Franklyn Martin,

Steven Haynes

In News

Silicon Canals
Tech Funding News
3

1 day ago

GreyWolf Therapeutics raised a $49.6M Series B led by ICG’s Life Sciences team
Oxfordshire-based Grey Wolf Therapeutics develops antigen modulation therapies for oncology and autoimmunity.
GreyWolf Therapeutics

Founders

Peter Joyce

In News

EU-Startups
4

2 days ago

Praktika raised a $32.5M Series A led by Blue Wire Capital
London-based Praktika delivers AI-powered language learning with personalized avatars.

Founders

Carles Reina,

Adam Turaev

In News

FinSMEs
Tech Funding News
5

3 days ago

Pheon Therapeutics raised a $120M Series B led by Research Corporation Technologies
London-based Pheon Therapeutics is an ADC specialist developing next-generation ADCs for hard-to-treat cancers.
Pheon Therapeutics

Founders

Cyrus Mozayeni

In News

FinSMEs
The pharma letter
Informazione
Spot a snag? Report it.
raised@truesparrow.com
Made with ❤️ by True Sparrow
© 2024 True Sparrow Systems Pvt. Ltd. All rights reserved.